Personalized Radiotherapy

Dear Colleagues,

Radiotherapy is one the main methods of cancer treatment, being used for half of all patients. Since the introduction of radiotherapy treatment, radiation oncologists and medical physicists have adapted radiation beam parameters to tumour size, shape, and localization in the body willing to eliminate cancer and keep healthy organs intact. Biologists have contributed significantly, providing knowledge on tumour and normal tissue sensitivity and factors influencing their response to radiation. The advancement in science, developments in technology, and increasing clinical evidence today allow to tailor treatment to each patient. Today, we adapt therapy to tumour properties, its morphology (dominant lesions) and metabolic properties, with emphasis on genetic factors and the underlying immunological status. We also try to reduce low doses, which occur in peripheral organs.

We welcome papers dealing with all aspects aimed to widen the knowledge on the tumour and healthy organ response to radiation in concomitance to other anticancer treatments or pre-existing factors. In particular, we invite papers focusing on radiotherapy individualization, leading to better results and improved patient comfort and safety.

Prof. Dr. Julian Malicki
Prof. Dr. Petera Jiří
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.